CXCL8 and chronic obstructive pulmonary disease: Oral nicotinamide riboside given over 5 weeks increased plasma NAD+ in patients with COPD and reduced sputum CXCL8 concentrations, with some evidence of reduced epigenetic aging, although no direct evidence that cellular senescence is reduced (Norheim et al, 2024).